COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy

NCT02278068 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Endocrine, Nutritional and Metabolic Diseases (E00-E89)

Interventions

DEVICE: Metabolic Neuromodulation System (MNS)

Sponsor

Metavention